Published in Kidney Int on January 02, 2013
Spine Trabecular Bone Score as an Indicator of Bone Microarchitecture at the Peripheral Skeleton in Kidney Transplant Recipients. Clin J Am Soc Nephrol (2017) 0.78
Type 1 diabetes and osteoporosis: A review of literature. Indian J Endocrinol Metab (2014) 0.77
Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management. Biomed Res Int (2015) 0.76
Changes in bone mineral density following long-term simultaneous pancreas-kidney transplantation. J Bone Miner Metab (2015) 0.75
Choices in kidney transplantation in type 1 diabetes: are there skeletal benefits of the endocrine pancreas? Kidney Int (2013) 0.75
Bone Disease after Kidney Transplantation. Clin J Am Soc Nephrol (2016) 0.75
Transplantation: Pancreas-kidney transplantation may reduce fracture risk in men with type 1 diabetes mellitus. Nat Rev Nephrol (2013) 0.75
Diabetes and other endocrine-metabolic abnormalities in the long-term follow-up of pancreas transplantation. Clin Diabetes Endocrinol (2016) 0.75
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med (1998) 32.43
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res (2007) 14.84
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int (2006) 5.50
High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol (2007) 4.11
Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int (2000) 3.29
The future of hip fractures in the United States. Numbers, costs, and potential effects of postmenopausal estrogen. Clin Orthop Relat Res (1990) 2.24
Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis (2000) 2.19
Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol (2006) 1.92
Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol (2006) 1.91
Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev (2007) 1.88
Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care (2001) 1.84
Risk of hip fracture among dialysis and renal transplant recipients. JAMA (2002) 1.81
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia (2005) 1.79
Trabecular bone histomorphometry in humans with Type 1 Diabetes Mellitus. Bone (2011) 1.61
Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J Bone Miner Res (1997) 1.45
Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int (2006) 1.44
Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int (2000) 1.44
Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med (1991) 1.42
Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int (2008) 1.40
Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Am J Med (1997) 1.34
IGF-1 and IGF-binding proteins and bone mass, geometry, and strength: relation to metabolic control in adolescent girls with type 1 diabetes. J Bone Miner Res (2008) 1.31
Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int (2006) 1.23
Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. J Bone Miner Res (1996) 1.20
Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden. Diabetes Care (2005) 1.20
Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int (2003) 1.19
Increased risk of hip fracture among men with CKD. Am J Kidney Dis (2008) 1.16
Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res (1999) 1.12
Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am J Surg (1993) 1.12
Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteoporos Int (2000) 1.12
Risk factors for hip fracture in white men: the NHANES I Epidemiologic Follow-up Study. J Bone Miner Res (1998) 1.06
Impact of peripheral neuropathy on bone density in patients with type 1 diabetes. Diabetes Care (1999) 1.05
Simultaneous pancreas-kidney and pancreas transplantation. J Am Soc Nephrol (2001) 1.04
Forearm endothelial function and bone mineral loss in postmenopausal women. Atherosclerosis (2004) 1.03
Hospitalizations for fractures after renal transplantation in the United States. Ann Epidemiol (2001) 1.02
Mild renal dysfunction is a risk factor for a decrease in bone mineral density and vertebral fractures in Japanese postmenopausal women. J Clin Endocrinol Metab (2010) 1.01
Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis (2006) 1.00
Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol (2006) 0.99
Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology (1989) 0.98
Risk of fractures after renal transplantation in the United States. Transplantation (2009) 0.95
Prevalence and causes of low bone density and fractures in kidney transplant patients. J Bone Miner Res (2001) 0.95
Can DXA predict fractures in renal transplant patients? Am J Transplant (2008) 0.95
Reduced fracture risk with early corticosteroid withdrawal after kidney transplant. Am J Transplant (2011) 0.94
Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy. Endocrinology (1981) 0.93
Pancreas transplantation improves vascular disease in patients with type 1 diabetes. Diabetes Care (2004) 0.90
Increased fracture rate in diabetes mellitus and females after renal transplantation. Transplantation (1999) 0.90
Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol (1998) 0.90
Changes in bone mass early after kidney transplantation. J Bone Miner Res (1994) 0.89
Compression fractures of the dorsal spine in hypoglycaemic fits in diabetes. Br Med J (Clin Res Ed) (1985) 0.86
Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron (1994) 0.86
Risk factors for fractures in kidney transplantation. Transplantation (2002) 0.85
Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes (1993) 0.83
Pancreas transplantation for patients with type 1 diabetes. Diabetes Care (2003) 0.83
Long-term outcome of simultaneous kidney-pancreas transplantation: analysis of 61 patients with more than 5 years follow-up. Transplantation (2000) 0.82
Bone loss in long-term renal transplantation: histopathology and densitometry analysis. Kidney Int (1999) 0.81
End stage renal disease and Medicare. Health Care Financ Rev (2003) 0.81
Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation (1996) 0.79
Low bone mass and high incidence of fractures after successful simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant (1998) 0.79
Long-term follow-up study on bone mineral density and fractures after simultaneous pancreas-kidney transplantation. Kidney Int (2004) 0.79
Lumbar bone mineral density in very long-term renal transplant recipients: impact of circulating sex hormones. Osteoporos Int (2005) 0.79
Factors influencing vertebral bone density after renal transplantation. Transplantation (1994) 0.79
Pattern of bone loss after simultaneous pancreas-kidney transplantation: a prospective study. Transplant Proc (1998) 0.76
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54
Clinical end points in coronary stent trials: a case for standardized definitions. Circulation (2007) 10.31
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med (2007) 7.60
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res (2009) 5.20
Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol (2007) 4.99
Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med (2015) 4.27
Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg (2006) 3.77
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45
Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N Engl J Med (2004) 3.44
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol (2012) 3.29
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet (2013) 3.17
Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 3.11
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. JAMA (2007) 3.07
High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol (2009) 2.97
Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. Kidney Int (2010) 2.95
Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int (2011) 2.94
Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med (2008) 2.85
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78
Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med (2006) 2.76
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation (2006) 2.72
Concordance of physician ratings with the appropriate use criteria for coronary revascularization. J Am Coll Cardiol (2011) 2.62
Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med (2003) 2.59
A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg (2005) 2.56
A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. J Am Coll Cardiol (2005) 2.56
Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol (2012) 2.56
Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA (2007) 2.49
Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate. J Bone Miner Res (2010) 2.37
Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res (2011) 2.30
The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg (2008) 2.29
Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis (2010) 2.20
Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial. J Am Coll Cardiol (2003) 2.18
Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol (2006) 2.18
Does competition for transplantable hearts encourage 'gaming' of the waiting list? Health Aff (Millwood) (2004) 2.15
The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab (2008) 2.12
Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med (2012) 2.09
The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol (2006) 2.05
Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative. J Am Coll Cardiol (2007) 2.03
High-resolution peripheral quantitative computed tomography can assess microstructural and mechanical properties of human distal tibial bone. J Bone Miner Res (2010) 2.01
Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation. Transplantation (2014) 2.00
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg (2012) 1.99
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J (2006) 1.98
Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke (2007) 1.96
Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol (2006) 1.91
State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3. Value Health (2012) 1.90
Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. Arch Intern Med (2012) 1.89
Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics (2005) 1.89
Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. J Clin Endocrinol Metab (2013) 1.88
Short-term bone loss in HIV-infected premenopausal women. J Acquir Immune Defic Syndr (2010) 1.87
Differences in bone microarchitecture between postmenopausal Chinese-American and white women. J Bone Miner Res (2011) 1.86
Vascular closure devices: the second decade. J Am Coll Cardiol (2007) 1.84
Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis. Eur Heart J (2014) 1.82
Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation (2005) 1.80
Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry. J Cardiovasc Electrophysiol (2007) 1.79
Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation (2011) 1.79
Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation (2011) 1.78
Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures. J Bone Miner Res (2010) 1.78
Chronic kidney disease and bone fracture: a growing concern. Kidney Int (2008) 1.76
Application of high-resolution skeletal imaging to measurements of volumetric BMD and skeletal microarchitecture in Chinese-American and white women: explanation of a paradox. J Bone Miner Res (2009) 1.76
Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol (2003) 1.76
The Carotid Artery Revascularization and Endarterectomy (CARE) registry: objectives, design, and implications. Catheter Cardiovasc Interv (2008) 1.75
Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res (2013) 1.74
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg (2012) 1.74
Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation (2004) 1.72
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J (2012) 1.72
ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation (2009) 1.71
Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial. Stroke (2011) 1.69
Are drug-eluting stents cost-effective? It depends on whom you ask. Circulation (2006) 1.69
Bone fragility and collagen cross-links. J Bone Miner Res (2004) 1.68
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. Transplantation (2016) 1.68
Economic impact of same-day home discharge after uncomplicated transradial percutaneous coronary intervention and bolus-only abciximab regimen. JACC Cardiovasc Interv (2010) 1.67
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol (2011) 1.67
A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial. J Am Coll Cardiol (2006) 1.65
Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial. J Am Coll Cardiol (2006) 1.65